— Know what they know.
Not Investment Advice

ADVT OTC

Advantis Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -90.0% 5Y: -98.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 50 · $9785 mcap

Income Trends

Revenue
$827K +103.6% ▲
4Y CAGR: -16.9%
Gross Profit
$763K +160.7% ▲
4Y CAGR: +60.8%
Operating Income
-$23K +79.7% ▲
Net Income
-$24K +79.2% ▲
EPS (Diluted)
$-0.00 +75.8% ▲
EBITDA
-$23K +79.7% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY1999FY2015FY2016FY2017FY2018
Revenue$2M$37K$46K$406K$827K
YoY Growth+0.0%+0.0%+25.8%+776.6%+103.6%
Cost of Revenue$2M$22K$19K$114K$64K
Gross Profit$114K$15K$27K$293K$763K
Gross Margin6.6%40.7%58.1%72.1%92.3%
R&D Expenses$0$0$0$0$0
SG&A Expenses$3M$253K$243K$402K$785K
Operating Expenses$3M$255K$244K$406K$786K
Operating Income-$3M-$240K-$217K-$113K-$23K
Operating Margin-152.8%-651.5%-469.2%-27.8%-2.8%
Interest Expense$0$54$393$613$678
Income Before Tax$0$109K-$106K-$114K-$24K
Tax Expense$64K$0$0$0$0
Net Income-$3M$109K-$106K-$114K-$24K
Net Margin-156.4%294.9%-228.9%-28.0%-2.9%
EPS (Diluted)$0.00$0.00$-0.00$-0.00$-0.00
EBITDA-$2M$109K-$106K-$113K-$23K
Shares Outstanding0708M919M978M978M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms